|Day Low/High||62.38 / 63.94|
|52 Wk Low/High||59.07 / 86.31|
The market rally may be a rising tide, but investors should be wary of some of the stocks it has lifted up.
No one wants a Kraft Heinz moment.
Dividend reinvestment plans (DRIPs) are compound interest to the extreme. Here are an expert's top-10 DRIP stocks for 2019.
File this under interesting. We all have come to accept that Amazon is attacking traditional retail, and that has led to a number of retailers flaming out while others look to defend, if not expand, their turf. For what it's worth, Walmart is doing ...
Walgreens earns a high mark for financial strength, while posting good numbers for earnings predictability and share price stability as well.
From small-cap genetics and biotech firms to large-cap drug distributors and pharmacies, eight experts select their top picks in the space for this year.
This shutdown is starting to feel different from those that we have experienced in the past, is it not?
It's likely that investors will be closely watching the U.S.-China trade talks to see if the skies brighten longer term.
Fed Chair Jerome Powell appears intent to reverse a near decade's worth of policy in just a couple of years.
Underwater positions on stocks you feel lukewarm about are prime candidates for tax selling.
Our index of 30 cutting-edge companies fell ... but not as much as the Nasdaq did.
Focus on facts when evaluating WBA's latest quarterly results.
The big, bad wolf showed up at the door on Wednesday, but here are ways to deal with him.
CNBC is reporting that Kroger and Walgreens Boots Alliance are "exploring a partnership to offer customers a new service that allows them to pick up groceries ordered online at Kroger at certain Walgreens locations..." Yes this signals that more ch...
Straying from these names could land you in quicksand as the 4th quarter begins.
We forgot that this nation is a nation based on consumption, not on industry, on sales, not on making things.
Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.
Rite Aid CEO John Standley faces shareholders's scrutiny after the merger flop.
After a failed merger with Albertsons, Rite Aid faces a difficult time on its own in a changing landscape.
A week of bad news for Ride Aid may be good news for its competitors Walgreens and CVS.
Prime Day 2018 is expected to generate $3.4 billion in sales, according to Coresight Research.
Here's to FANG for once again exciting and enthralling and defying all of the negatives.